Literature DB >> 7496081

Renal refractoriness to phosphaturic action of parathyroid hormone in a patient with hypomagnesemia.

M Mihara1, K Kamikubo, K Hiramatsu, S Itaya, T Ogawa, S Sakata.   

Abstract

A 50-year-old tetanic woman with hypomagnesemia is described. She had partial resection of the stomach and the jejunum at the age of 20 years. Lack of parathyroid hormone (PTH) function was indicated by hypocalcemia, hyperphosphatemia and high tubular reabsorption of phosphate. However, both plasma concentration of PTH and nephrogenous cAMP were normal. Administration of magnesium sulfate completely normalized serum phosphate and tubular transport of phosphate with only a modest increase in nephrogenous cAMP. The present findings suggest that phosphaturic action of PTH is impaired in magnesium deficiency and that steps distal to cAMP production may be responsible for the renal refractoriness to the hormonal action.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7496081     DOI: 10.2169/internalmedicine.34.666

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

Review 1.  Drug-induced hypomagnesaemia : scope and management.

Authors:  Jacob Atsmon; Eran Dolev
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Acute-onset hypomagnesemia-induced hypocalcemia caused by the refractoriness of bones and renal tubules to parathyroid hormone.

Authors:  Masahiro Yamamoto; Toru Yamaguchi; Mika Yamauchi; Shozo Yano; Toshitsugu Sugimoto
Journal:  J Bone Miner Metab       Date:  2011-05-19       Impact factor: 2.626

Review 3.  Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus.

Authors:  Aliya A Khan; Christian A Koch; Stan Van Uum; Jean Patrice Baillargeon; Jens Bollerslev; Maria Luisa Brandi; Claudio Marcocci; Lars Rejnmark; Rene Rizzoli; M Zakarea Shrayyef; Rajesh Thakker; Bulent O Yildiz; Bart Clarke
Journal:  Eur J Endocrinol       Date:  2019-03       Impact factor: 6.664

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.